Sanguine Media: No Fund Deviation in FY26

Key Disclosure Content

The company has submitted this disclosure pursuant to SEBI circular CIR/CFD/CMD/11621/2019 dated 24th December, 2019 (as amended from time to time).

Financial Activity Status

Sanguine Media Limited confirms that there was no Public Issue, Rights Issue, Preferential Issue, or Qualified Institutions Placement (QIP) during both:

• The quarter ended March 31, 2026
• The year ended March 31, 2026

Regulatory Conclusion

As a result of having no capital raising activities during the specified periods, the Statement of Deviation or Variation under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the company for the quarter and year ended March 31, 2026.